Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary: Elite Pharmaceuticals Inc /Nv/ quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
Elite Pharmaceuticals Inc /Nv/ Nonoperating Income (Expense) for the quarter ending December 31, 2024 was -$11.8M, a 224% decline year-over-year.
Elite Pharmaceuticals Inc /Nv/ Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was -$29.5M, a 226% decline year-over-year.
Elite Pharmaceuticals Inc /Nv/ annual Nonoperating Income (Expense) for 2023 was -$10.3M, a 3432% decline from 2022.
Elite Pharmaceuticals Inc /Nv/ annual Nonoperating Income (Expense) for 2022 was $310K, a 74.9% decline from 2021.
Elite Pharmaceuticals Inc /Nv/ annual Nonoperating Income (Expense) for 2021 was $1.23M, a 39.5% decline from 2020.

Nonoperating Income (Expense), Trailing 12 Months (USD)

Nonoperating Income (Expense), Annual (USD)

Nonoperating Income (Expense), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	-$10.3M	-$10.6M	-3432%	Apr 1, 2023	Mar 31, 2024	10-K	2024-07-01
2022	$310K	-$924K	-74.9%	Apr 1, 2022	Mar 31, 2023	10-K	2024-07-01
2021	$1.23M	-$806K	-39.5%	Apr 1, 2021	Mar 31, 2022	10-K	2023-06-29
2020	$2.04M			Apr 1, 2020	Mar 31, 2021	10-K	2022-06-29
2015	$7.11M	-$14.6M	-67.3%	Apr 1, 2015	Mar 31, 2016	10-K	2016-06-15
2014	$21.7M	+$58M		Apr 1, 2014	Mar 31, 2015	10-K	2016-06-15
2013	-$36.3M	-$39M	-1445%	Apr 1, 2013	Mar 31, 2014	10-K	2016-06-15
2012	$2.7M	+$16.3M		Apr 1, 2012	Mar 31, 2013	10-K	2014-06-30
2011	-$13.6M	-$578K	-4.45%	Apr 1, 2011	Mar 31, 2012	10-K	2013-06-21
2010	-$13M			Apr 1, 2010	Mar 31, 2011	10-K	2012-06-29

Showing 1 to 10 of 10 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.